FMR CORP 13D and 13G filings for X4 Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2020-09-10 10:03 am Sale |
2020-09-09 | 13G | X4 Pharmaceuticals, Inc. XFOR |
FMR CORP | 817,300 4.915% |
-532,700 (-39.46%) |
Filing |